• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Recommendation to Subject Certain Medicines Used in the Treatment of COVID-19 Under Maximum Retail Price

ADVISORY October 25, 2021    RECOMMENDATION TO SUBJECT CERTAIN MEDICINES USED IN THETREATMENT OF COVID-19 UNDER MAXIMUM RETAIL PRICE   On 10 September 2021, Proclamation No. 1218 extended the State continue reading : Recommendation to Subject Certain Medicines Used in the Treatment of COVID-19 Under Maximum Retail Price